The rare enterovirus c99 and echovirus 29 strains in Brazil: potential risks associated to silent circulation.
Journal
Memorias do Instituto Oswaldo Cruz
ISSN: 1678-8060
Titre abrégé: Mem Inst Oswaldo Cruz
Pays: Brazil
ID NLM: 7502619
Informations de publication
Date de publication:
2019
2019
Historique:
received:
30
04
2019
accepted:
17
07
2019
entrez:
15
8
2019
pubmed:
15
8
2019
medline:
5
9
2019
Statut:
ppublish
Résumé
Human enteroviruses (EVs) are associated with a wide spectrum of human diseases. Here we report the complete genome sequences of one EV-C99 strain and one E29 strain obtained from children suffering from acute gastroenteritis, without symptoms of enteroviral syndromes. This is the first report of EV-C99 in South America, and the second E29 genome described worldwide. Continuous surveillance on EVs is vital to provide further understanding of the circulation of new or rare EV serotypes in the country. The present study also highlights the capacity of EVs to remain in silent circulation in populations.
Identifiants
pubmed: 31411312
pii: S0074-02762019000100415
doi: 10.1590/0074-02760190160
pmc: PMC6690645
pii:
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e190160Références
Commun Dis Public Health. 1999 Jun;2(2):122-5
pubmed: 10402747
J Gen Virol. 2000 Mar;81(Pt 3):803-12
pubmed: 10675418
Am J Hyg. 1964 Jan;79:7-15
pubmed: 14117623
Clin Infect Dis. 2004 Jan 1;38(1):70-7
pubmed: 14679450
J Med Microbiol. 2005 Jan;54(Pt 1):63-9
pubmed: 15591257
J Gen Virol. 2006 Jan;87(Pt 1):119-28
pubmed: 16361424
MMWR Morb Mortal Wkly Rep. 2006 Feb 17;55(6):153-6
pubmed: 16484979
MMWR Surveill Summ. 2006 Sep 15;55(8):1-20
pubmed: 16971890
Appl Environ Microbiol. 2008 Mar;74(5):1453-63
pubmed: 18192407
J Med Virol. 2008 Jun;80(6):1018-24
pubmed: 18428125
J Gen Virol. 2009 Jul;90(Pt 7):1713-23
pubmed: 19264596
Arch Virol. 2012 Mar;157(3):551-4
pubmed: 22193975
J Gen Virol. 2012 Nov;93(Pt 11):2357-62
pubmed: 22894922
J Virol. 2012 Nov;86(22):12161-75
pubmed: 22933275
Emerg Infect Dis. 2012 Nov;18(11):1833-40
pubmed: 23092622
Arch Virol. 2014 Feb;159(2):359-64
pubmed: 24013237
Mol Biol Evol. 2013 Dec;30(12):2725-9
pubmed: 24132122
PLoS One. 2014 Apr 10;9(4):e94579
pubmed: 24722726
Virus Res. 2014 Aug 30;189:189-93
pubmed: 24915283
PLoS Negl Trop Dis. 2014 Jul 31;8(7):e3052
pubmed: 25079078
J Virol Methods. 2015 Mar;213:139-46
pubmed: 25497414
Nucleic Acids Res. 2015 Apr 20;43(7):e46
pubmed: 25586223
J Gen Virol. 2015 Jun;96(Pt 6):1374-9
pubmed: 25667329
PLoS One. 2015 Aug 24;10(8):e0136700
pubmed: 26301510
J Clin Virol. 2015 Oct;71:40-3
pubmed: 26370313
Sci Rep. 2016 Sep 19;6:33595
pubmed: 27642136
Hum Vaccin Immunother. 2017 Mar 4;13(3):717-723
pubmed: 27901633
Sci Rep. 2017 Jun 19;7(1):3808
pubmed: 28630462
Virol J. 2017 Sep 12;14(1):175
pubmed: 28899411
Emerg Infect Dis. 2017 Oct;23(10):1742-1744
pubmed: 28930031